Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dr. Reddy's to Market Joint Supplement as Drug in India - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Dr. Reddy’s to Market Joint Supplement as Drug in India

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Imagenetix, Inc., San Diego, CA, the developer of Celadrin, a natural compound for joint health, has formed a partnership with Cymbiotics, Inc., San Diego, CA, and Dr. Reddy’s Laboratories, a pharmaceutical company in Hyderabad, India, to launch Cela­drin as a pharmaceutical in India. Celadrin has been approved for use as a drug in India to help reduce pain and inflammation in patients with joint conditions.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics